Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
3.
Eur J Ophthalmol ; 17(6): 879-84, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-18050111

RESUMO

PURPOSE: Pterygium is a proliferative, inflammatory, and invasive ocular surface disease associated with excessive ultraviolet radiation exposure and has several tumor-like characteristics. Cyclooxygenase-2 (COX-2) is an inducible enzyme and recently increased expression of the enzyme was found in many cancers and premalign lesions. This study was conducted to identify the COX-2 expression in pterygium tissues. METHODS: Immunohistochemical staining using a primary antibody for COX-2 was performed on 30 specimens with primary pterygium (20 pterygium without recurrence and 10 pterygium which recurred during a 12-month follow-up), 11 specimens with recurrent pterygium, and 8 specimens of conjunctival tumor. As a control we used 10 specimens of normal conjunctiva. Extent and intensity of cytoplasmic and membranous staining in epithelial cells were evaluated. RESULTS: Higher expression of COX-2 was detected in conjunctival tumor (87.5%) specimens and recurrent pterygium specimens (72.7%) compared to the both normal conjunctiva (30%) and primary pterygium without recurrence (30%). COX-2 expression in primary pterygium tissues with recurrence (60%) was not different from primary pterygium without recurrence (p=0.114) and recurrent pterygium (p=0.537). However, recurrent pterygium tissues were found to express higher COX-2 than primary pterygium without recurrence (p=0.022). CONCLUSIONS: COX-2 expression is increased in recurrent pterygium tissues and COX-2 expression may be a marker for the prediction of recurrence.


Assuntos
Biomarcadores/metabolismo , Ciclo-Oxigenase 2/metabolismo , Pterígio/enzimologia , Neoplasias da Túnica Conjuntiva/enzimologia , Humanos , Técnicas Imunoenzimáticas , Recidiva
6.
Acta Chir Belg ; 105(2): 224-6, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15906923

RESUMO

Primary signet ring cell carcinoma of the breast is a very rare tumour. We present a case with pure signet ring cell carcinoma of the breast, which was recognized as metastasis on the pelvic floor, before developing breast symptoms and signs. A 40-year old woman was admitted with abdominal pain. First diagnostic effort revealed a cystic mass on the pelvic floor, compressing the colon and other neighbouring organs. A biopsy of the pelvic mass was performed. The histopathological examination revealed metastatic signet-ring cell carcinoma. At the time of the first operation, the mammary glands were not suspicious. No other sources of primary tumour were evidenced. An inflammatory sign developed in right breast two months after biopsy of the pelvic metastasis. The histopathology of the breast incisional biopsy revealed primary pure signet ring cell carcinoma of the breast. Because the oestrogen and progesterone receptor were negative in the tumoral tissue, the patient underwent chemotherapy followed by modified radical mastectomy, chemotherapy, and palliative resection of the metastatic mass. The patient was followed up for eight months. To our knowledge, in English literature, we believe that this case is the first report of signet ring cell carcinoma of the breast presenting with pelvic floor metastasis without breast sign.


Assuntos
Neoplasias da Mama/patologia , Neoplasias da Mama/terapia , Carcinoma de Células em Anel de Sinete/secundário , Carcinoma de Células em Anel de Sinete/terapia , Neoplasias Pélvicas/secundário , Adulto , Biópsia por Agulha , Carcinoma de Células em Anel de Sinete/patologia , Quimioterapia Adjuvante , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Mastectomia Radical Modificada/métodos , Estadiamento de Neoplasias , Diafragma da Pelve , Neoplasias Pélvicas/patologia , Neoplasias Pélvicas/cirurgia , Doenças Raras , Medição de Risco , Resultado do Tratamento
7.
Eur J Ophthalmol ; 15(2): 233-8, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15812766

RESUMO

PURPOSE: To investigate retinal cell apoptosis in an experimental transient, short duration ocular ischemia model. METHODS: An experimental ischemia model, which simulates creating temporary high intraocular pressure to control intraocular bleeding during pars plana vitrectomy, was set up. Rabbits were randomly divided into three groups. Group 1 was the control group. In Group 2, intraocular pressure was increased to 97 mmHg for 5 minutes. In Group 3, intraocular pressure was increased to 97 mmHg for 10 minutes. After 24 hours, terminal deoxyribonucleotidyl transferase-mediated dUTP-digoxigenin nick-end labeling assay was used to detect retinal apoptosis in rabbit eyes. Only nuclear staining in retinal cells was counted. RESULTS: Groups with 5 minutes and 10 minutes of ischemia showed significantly higher amount of ganglion cell layer apoptosis when compared with the control group (p<0.05). Light microscopy and standard hematoxylin-eosin did not show any significant damage in the retina cells. CONCLUSIONS: Apoptotic cell death in the retinal cell layers occurs in temporary ischemia-reperfusion as early as 5 and 10 minutes duration.


Assuntos
Apoptose , Traumatismo por Reperfusão/diagnóstico , Artéria Retiniana/patologia , Doenças Retinianas/diagnóstico , Células Ganglionares da Retina/patologia , Animais , Modelos Animais de Doenças , Marcação In Situ das Extremidades Cortadas , Pressão Intraocular , Hipertensão Ocular/complicações , Coelhos , Traumatismo por Reperfusão/etiologia , Doenças Retinianas/etiologia
8.
Ann Chir ; 129(5): 273-7, 2004 Jun.
Artigo em Francês | MEDLINE | ID: mdl-15220100

RESUMO

PURPOSE: Bacterial translocation leading to sepsis is increased by obstructive jaundice(OJ). Antithrombin III (ATIII) mediates the promotion of prostaglandin release, an inhibitor of leucocyte activation and downregulator of many proinflammatory cytokines. We investigated the effect of ATIII on histopatology and villus morphology of small intestine. MATERIAL AND METHODS: We designed an experimental study with 40 rats who were divided into four groups. The first one (control, n = 10) received saline, the second (n = 10) included normal rats who received ATIII, the third group (n = 10) was rats with OJ (ligation of common bile duct), and the fourth group included OJ rats receiving AT-III. AT-III (100 UI/kg intraperitoneally) was started at the third day following bile duct ligation and repeated for 5 days. At the 8 day, rats were scarified and ileum was analysed. Histopathological assessments were performed, using a grading scheme ranging from 0 to 10 (Chui et al). RESULTS: Median histological score was found to be 2 in group 1, 1.71 in group 2, 5.43 in group 3 and 2.71 in group 4. The difference between group 3 and 4 was statistically significant. Mucosal thicknesses and villus lengths were found significantly lower in OJ group. Mucosal thicknesses and villus lengths were significantly preserved in jaundiced + AT-III group. CONCLUSION: ATIII demonstrated a salutary effect on the histopathological changes caused by the OJ and prevented the adverse effects on histopathological and morphological parameters in ileal mucosa.


Assuntos
Antitrombina III/uso terapêutico , Modelos Animais de Doenças , Íleo , Mucosa Intestinal , Icterícia Obstrutiva , Inibidores de Serina Proteinase/uso terapêutico , Animais , Antitrombina III/farmacologia , Translocação Bacteriana/efeitos dos fármacos , Ducto Colédoco/cirurgia , Citocinas/efeitos dos fármacos , Regulação para Baixo/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos , Endotoxemia/etiologia , Hemorragia Gastrointestinal/etiologia , Hiperemia/etiologia , Íleo/efeitos dos fármacos , Íleo/imunologia , Íleo/patologia , Imunidade nas Mucosas/efeitos dos fármacos , Imunidade nas Mucosas/imunologia , Inflamação , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/imunologia , Mucosa Intestinal/patologia , Icterícia Obstrutiva/complicações , Icterícia Obstrutiva/tratamento farmacológico , Icterícia Obstrutiva/imunologia , Icterícia Obstrutiva/patologia , Leucócitos/efeitos dos fármacos , Ligadura , Prostaglandinas , Distribuição Aleatória , Ratos , Ratos Wistar , Inibidores de Serina Proteinase/farmacologia , Índice de Gravidade de Doença
9.
J Exp Clin Cancer Res ; 22(3): 441-5, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-14582704

RESUMO

The antibody 34-betaE12 stains selectively the keratins of basal cells. The aim of this study is to investigate the staining pattern of 34-betaE12 in borderline (keratoacanthomas and solar keratosis), and benign lesions (seborrheic keratoses). The proliferation index Ki-67 staining was also evaluated in these and also in malignant (basal and squamous cell carcinomas) cases. The staining pattern where the 34-betaE12 positive cells found in the basal, suprabasal epidermal layers was called "focal"; and the staining in all layers including upper spinous layer was called "diffuse". Mean proliferation index and the distribution pattern of Ki-67 immunohistochemical expression were assessed. Basal and suprabasal expression of 34-betaE12 significantly predominated in the normal parts of the epidermis, in eight out of 11 seborrheic keratoses (%73), one out of the 19 keratoacanthomas (%5), two out of 11 solar keratosis (18%). Statistical analysis revealed significant differences between mean level of Ki-67 expression of malignant (squamous cell carcinoma, basal cell carcinoma), benign (seborrheic keratoses) and premalignant (solar keratoses, keratoacanthomas) lesions (p<0.01). The distribution of staining pattern for Ki-67 paralleled to the staining pattern of 34-betaE12. Basal cell status assessment completed by 34-betaE12 may resolve some, but not all of the problems in terms of determining the presence of dysplasia.


Assuntos
Queratinas/metabolismo , Antígeno Ki-67/metabolismo , Lesões Pré-Cancerosas/metabolismo , Lesões Pré-Cancerosas/patologia , Pele/metabolismo , Pele/patologia , Divisão Celular , Humanos , Imuno-Histoquímica , Ceratoacantoma/metabolismo , Ceratoacantoma/patologia , Ceratose/metabolismo , Ceratose/patologia , Ceratose Seborreica/metabolismo , Ceratose Seborreica/patologia
10.
Clin Exp Dermatol ; 28(4): 377-9, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12823297

RESUMO

We report a case of recurrent localized Sweet's syndrome (SS) with pulmonary sarcoidosis and hepatitis C virus infection. Hepatitis C may be the triggering factor for both Sweet's syndrome and sarcoidosis through stimulation of T helper 1 immune responses involved in the pathogenesis of both diseases.


Assuntos
Dermatoses da Mão/virologia , Hepatite C Crônica/complicações , Pneumopatias/virologia , Sarcoidose/virologia , Síndrome de Sweet/virologia , Feminino , Humanos , Pessoa de Meia-Idade
11.
Eur J Gynaecol Oncol ; 23(4): 345-6, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12214741

RESUMO

A 45-year-old postmenopausal woman, Gravida6, Para4, Abortus0, Dilatation x Curhetage2, came to the gynaecology department with pelvic pain. The tumor had arisen in the right ovary and measured 15 x 12 x 7 cm. Its cut surface varied from grey-white with a whorled appearance and showed areas of haemorrhage. Histologically the tumor was densely cellular, composed of spindle cells, diffusely involved the entire ovarian stroma with no normal ovarian structures remaining. Tumor cells had hyperchromatic nuclei with prominent nucleoli. There was moderate pleomorphism and the number of mitotic figures was an average of 6 per 10 high power fields. In the immunohistochemical study, the tumor was negative for desmin, muscle-specific actin, estrogen, progesterone receptors and CD31, but was positive for vimentin. A low proliferation index with Ki-67 was determined. The patient has shown no evidence of recurrent disease for five years.


Assuntos
Fibrossarcoma/diagnóstico , Neoplasias Ovarianas/diagnóstico , Dor Abdominal/etiologia , Apendicectomia , Diagnóstico Diferencial , Feminino , Fibrossarcoma/complicações , Fibrossarcoma/patologia , Fibrossarcoma/cirurgia , Humanos , Histerectomia , Pessoa de Meia-Idade , Omento/cirurgia , Neoplasias Ovarianas/complicações , Neoplasias Ovarianas/patologia , Neoplasias Ovarianas/cirurgia , Ovariectomia , Pós-Menopausa , Salpingostomia , Sobreviventes
12.
Neoplasma ; 49(2): 95-100, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12088113

RESUMO

Helicobacter pylori (H. pylori) infection is associated with changes in epithelial turnover, through their significance of these in gastric carcinogenesis is still controversial. The purpose of this study was to determine the influence of H. pylori infection on cell proliferation and the relation with the cell-cycle regulators, and finally to provide insights into the mechanism by which H. pylori may lead to gastric carcinogenesis. We investigated Ki-67, p53, p21(Waf1/Cip1), cyclin D1 expression in 55 patients with H. pylori gastritis, and compared the results with patients those of non-H. pylori gastritis patients (n=21), gastric adenocarcinoma patients (n=8) and samples with normal gastric mucosa (n=12). Gastric biopsies were histologically evaluated for inflammatory reaction, intestinal metaplasia and atrophy according to the Sydney system. Overexpression of Ki-67, p53, p21(Waf1/Cip1) and cyclin D1 was found in H. pylori gastritis patients (32.7%, 10.9%, 20.0% and 7.3%, respectively), whereas only scattered expression in cells in the neck region of the crypts, but no overexpression was found in gastric antral epithelial cells in biopsy specimens from patients with non-H. pylori gastritis and noninflammed mucosa. A significant relationship was found between the grade of H. pylori colonization and Ki-67, p53, p21(Waf1/Cip1) and cyclin D1 expression. Expression was significantly higher in patients with intestinal metaplasia with atrophy, whereas no overexpression was found in patients without intestinal metaplasia with atrophy (p=0.05). H. pylori infection is associated with increased cell proliferation, increased epithelial DNA damage, and atrophy, which might contribute to the development of gastric cancer. Even if the exact mechanism has not been elucidated yet, our results suggest that H. pylori infection acts as a cofactor in gastric carcinogenesis.


Assuntos
Proteínas de Ciclo Celular/biossíntese , Ciclo Celular/fisiologia , Ciclinas/biossíntese , Gastrite/microbiologia , Infecções por Helicobacter/patologia , Helicobacter pylori/citologia , Helicobacter pylori/patogenicidade , Antígeno Ki-67/biossíntese , Neoplasias Gástricas/microbiologia , Proteína Supressora de Tumor p53/biossíntese , Adenocarcinoma/patologia , Biópsia , Divisão Celular , Ciclina D1/biossíntese , Inibidor de Quinase Dependente de Ciclina p21 , Mucosa Gástrica/citologia , Mucosa Gástrica/patologia , Gastrite/complicações , Gastrite/patologia , Infecções por Helicobacter/complicações , Humanos , Valores de Referência
14.
Acta Cardiol ; 55(5): 295-300, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11103829

RESUMO

OBJECTIVE: Chlamydia pneumoniae, which is a Gram(-) intracellular bacteria, besides being a respiratory pathogen, is thought to play an active role in the progress of acute myocardial infarction and chronic coronary artery disease. In this study we aim to determine the frequency of C. pneumoniae in coronary artery lesions of Turkish people. METHODS AND RESULTS: The atherosclerotic material taken from 8 cases by directional atherectomy and from 23 cases by surgical endarterectomy and examined by indirect immunofluorescence (IIFA) test and polymerase chain reaction (PCR). C. pneumoniae positivity was 32.3% (10/31) by IIFA and 29.0% (9/31) by PCR while the evaluation of the methods together yield a positivity of 35.5% (11/31). CONCLUSIONS: A statistically significant difference could not be established between C. pneumoniae positive and negative groups according to age and the classical atherosclerotic risk factors such as diabetes mellitus, smoking, hypercholesterolaemia, hypertension, family history; besides, a statistically significant difference could not be found between the presence of C. pneumoniae and the severity and clinical picture of coronary artery disease.


Assuntos
Infecções por Chlamydia/complicações , Doença da Artéria Coronariana/etiologia , Infecções por Chlamydia/epidemiologia , Chlamydophila pneumoniae/isolamento & purificação , Doença da Artéria Coronariana/epidemiologia , Doença da Artéria Coronariana/microbiologia , Feminino , Imunofluorescência , Humanos , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Fatores de Risco , Turquia/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA